Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00858481 · ClinicalTrials.gov registry record · Phase 2

A Pilot Dose Ranging Study of Spinosad Creme Rinse

A Phase 2 study of Head Lice and Pediculosis Capitis, sponsored by ParaPRO.

Completed
Registry status
Phase 2
Development phase
36
Enrollment target
1
Study location

NCT00858481 is a Phase 2 study of Head Lice and Pediculosis Capitis that has completed, run by ParaPRO. The registered enrollment target is 36 participants, below the 110-participant average among 5 other Head Lice trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00858481, a Phase 2 study of Head Lice and Pediculosis Capitis, has completed, sponsored by ParaPRO.

COMPLETED
Registry status
Phase 2
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.

Interventions

  • DRUG Spinosad Creme Rinse - Vehicle Control
  • DRUG Spinosad Creme Rinse

Study Locations (1)

Florida

  • Hill Top Research - West Palm Beach

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2005-09
Est. Completion 2005-11
Phase Phase 2

Sponsor

ParaPRO

11 total trials

What the Registry Record Tells You About NCT00858481

The ClinicalTrials.gov registry entry for NCT00858481 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 110-participant average among 5 other Head Lice trials with a reported enrollment target (67% lower). The listed sponsor is ParaPRO, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Head Lice appearing as the primary indexed condition, and to 2 interventions - of which Spinosad Creme Rinse - Vehicle Control is the first listed.

NCT00858481 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00858481 about?

NCT00858481 is a clinical study titled "A Pilot Dose Ranging Study of Spinosad Creme Rinse". A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.

What is the current status of trial NCT00858481?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2005-09. Estimated completion is 2005-11.

What conditions does trial NCT00858481 study?

This clinical trial studies the following conditions: Head Lice, Pediculosis Capitis.

What interventions are being tested in trial NCT00858481?

The interventions under investigation include: Spinosad Creme Rinse - Vehicle Control (DRUG), Spinosad Creme Rinse (DRUG).

Who is sponsoring clinical trial NCT00858481?

This trial is sponsored by ParaPRO, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00858481 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head Lice

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.